Skip to main content

Research Repository

Advanced Search

Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT

Sprigg, Nikola; Flaherty, Katie; Appleton, Jason P; Al-Shahi Salman, Rustam; Bereczki, Daniel; Beridze, Maia; Ciccone, Alfonso; Collins, Ronan; Dineen, Robert A; Duley, Lelia; Egea-Guerrero, Juan José; England, Timothy J; Karlinski, Michal; Krishnan, Kailash; Laska, Ann Charlotte; Law, Zhe Kang; Ovesen, Christian; Ozturk, Serefnur; Pocock, Stuart J; Roberts, Ian; Robinson, Thompson G; Roffe, Christine; Peters, Nils; Scutt, Polly; Thanabalan, Jegan; Werring, David; Whynes, David; Woodhouse, Lisa; Bath, Philip M

Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT Thumbnail


Authors

Katie Flaherty

Jason P Appleton

Rustam Al-Shahi Salman

Daniel Bereczki

Maia Beridze

Alfonso Ciccone

Ronan Collins

Lelia Duley

Juan José Egea-Guerrero

Michal Karlinski

Kailash Krishnan

Ann Charlotte Laska

Zhe Kang Law

Christian Ovesen

Serefnur Ozturk

Stuart J Pocock

Ian Roberts

Thompson G Robinson

Christine Roffe

Nils Peters

Polly Scutt

Jegan Thanabalan

David Werring

David Whynes



Abstract

BACKGROUND: Tranexamic acid reduces death due to bleeding after trauma and postpartum haemorrhage. OBJECTIVE: The aim of the study was to assess if tranexamic acid is safe, reduces haematoma expansion and improves outcomes in adults with spontaneous intracerebral haemorrhage (ICH). DESIGN: The TICH-2 (Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage) study was a pragmatic, Phase III, prospective, double-blind, randomised placebo-controlled trial. SETTING: Acute stroke services at 124 hospitals in 12 countries (Denmark, Georgia, Hungary, Ireland, Italy, Malaysia, Poland, Spain, Sweden, Switzerland, Turkey and the UK). PARTICIPANTS: Adult patients (aged ≥ 18 years) with ICH within 8 hours of onset. EXCLUSION CRITERIA: Exclusion criteria were ICH secondary to anticoagulation, thrombolysis, trauma or a known underlying structural abnormality; patients for whom tranexamic acid was thought to be contraindicated; prestroke dependence (i.e. patients with a modified Rankin Scale [mRS] score > 4); life expectancy

Citation

Sprigg, N., Flaherty, K., Appleton, J. P., Al-Shahi Salman, R., Bereczki, D., Beridze, M., Ciccone, A., Collins, R., Dineen, R. A., Duley, L., Egea-Guerrero, J. J., England, T. J., Karlinski, M., Krishnan, K., Laska, A. C., Law, Z. K., Ovesen, C., Ozturk, S., Pocock, S. J., Roberts, I., …Bath, P. M. (2019). Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. Health Technology Assessment, 23(35), 1-48. https://doi.org/10.3310/hta23350

Journal Article Type Article
Acceptance Date Mar 21, 2019
Publication Date Jul 1, 2019
Deposit Date Aug 12, 2019
Publicly Available Date Aug 12, 2019
Journal Health Technology Assessment
Print ISSN 1366-5278
Electronic ISSN 2046-4924
Publisher NIHR Journals Library
Peer Reviewed Peer Reviewed
Volume 23
Issue 35
Pages 1-48
DOI https://doi.org/10.3310/hta23350
Keywords Health Policy
Public URL https://nottingham-repository.worktribe.com/output/2417671
Publisher URL https://www.journalslibrary.nihr.ac.uk/hta/hta23350#/abstract
Contract Date Aug 12, 2019

Files





You might also like



Downloadable Citations